NVX-188

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNVX-188
Drug Alias Namealpha-V/beta-3 intergrin antagonist (Novelix)NVX-188
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsArthritis, RheumatoidOsteoporosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Southern California
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovelix PharmaceuticalsUniversity Of Southern California
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidOsteoporosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A